1. Simon A, Chironi G, Levenson J. Performance of Subclinical Arterial Disease Detection as a Screening Test for Coronary Heart Disease. Hypertension. 2006;48(3):392–6. DOI: 10.1161/01.HYP.0000236507.76042.72
2. Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, FunckBrentano C et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. European Heart Journal. 2020;41(3):407–77. DOI: 10.1093/eurheartj/ehz425
3. Viera AJ, Sheridan SL. Global risk of coronary heart disease: assessment and application. American Family Physician. 2010;82(3):265–74. PMID: 20672791
4. Cournot M, Bura A, Cambou J-P, Taraszkiewicz D, Maloizel J, Galinier M et al. Arterial Ultrasound Screening as a Tool for Coronary Risk Assessment in Asymptomatic Men and Women. Angiology. 2012;63(4):282–8. DOI: 10.1177/0003319711414865
5. Gepner AD, Young R, Delaney JA, Tattersall MC, Blaha MJ, Post WS et al. Comparison of Coronary Artery Calcium Presence, Carotid Plaque Presence, and Carotid Intima-Media Thickness for Cardiovascular Disease Prediction in the Multi-Ethnic Study of Atherosclerosis. Circulation: Cardiovascular Imaging. 2015;8(1):e002262. DOI: 10.1161/CIRCIMAGING.114.002262
6. Genkel V.V., Kuznetsova A.S., Sumerkina V.S., Salashenko A.O., Shaposhnik I.I. The prognostic value of various carotid ultrasound parameters in patients at high and very high cardiovascular risk. International Journal of Cardiology. 2019;292:225–9. DOI: 10.1016/j.ijcard.2019.06.038
7. Ершова А.И., Балахонова Т.В., Иванова А.А., Мешков А.Н., Бойцов С.А., Драпкина О.М. Проблема стратификации сердечно-сосудистого риска в зависимости от выраженности атеросклероза сонных и бедренных артерий. Кардиоваскулярная терапия и профилактика. 2020;19(2):75-81. DOI: 10.15829/1728-8800-2020-2441
8. Aboyans V, Ricco J-B, Bartelink M-LEL, Björck M, Brodmann M, Cohnert T et al. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS). European Heart Journal. 2018;39(9):763–816. DOI: 10.1093/eurheartj/ehx095
9. Tarantini G, Napodano M, Gasparetto N, Favaretto E, Marra MP, Cacciavillani L et al. Impact of multivessel coronary artery disease on early ischemic injury, late clinical outcome, and remodeling in patients with acute myocardial infarction treated by primary coronary angioplasty. Coronary Artery Disease. 2010;21(2):78–86. DOI: 10.1097/MCA.0b013e328335a074
10. Гаврилова Н.Е., Метельская В.А., Перова Н.В., Яровая Е.Б., Мазаев В.П., Уразалина С.Ж. и др. Взаимосвязь между выраженностью коронарного атеросклероза, факторами риска и маркерами атеросклеротического поражения каротидных и периферических артерий. Кардиоваскулярная терапия и профилактика. 2013;12(1):40-5. DOI: 10.15829/1728-8800-2013-1-40-45
11. Gavrilova N.E., Metelskaya V.A., Yarovaya E.B., Boytsov S.A. P477. Carotid artery ultrasound dopplerography for detection of coronary artery disease severity estimated by Gensini score. European Journal of Preventive Cardiology. 2014;21(1 Suppl):S84–113. DOI: 10.1177/2047487314534582
12. Меркулов Е.В., Миронов В.М., Самко А.Н. Коронарная ангиография, вентрикулография, шунтография в иллюстрациях и схемах. - М.: Медиа Медика, 2011. – 100с. ISBN 978-5-905305-03-0
13. Stein JH, Korcarz CE, Hurst RT, Lonn E, Kendall CB, Mohler ER et al. Use of Carotid Ultrasound to Identify Subclinical Vascular Disease and Evaluate Cardiovascular Disease Risk: A Consensus Statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force Endorsed by the Society for Vascular Medicine. Journal of the American Society of Echocardiography. 2008;21(2):93–111. DOI: 10.1016/j.echo.2007.11.011
14. Solberg LA, Eggen DA. Localization and Sequence of Development of Atherosclerotic Lesions in the Carotid and Vertebral Arteries. Circulation. 1971;43(5):711–24. DOI: 10.1161/01.CIR.43.5.711
15. Den Ruijter HM, Peters SAE, Anderson TJ, Britton AR, Dekker JM, Eijkemans MJ et al. Common Carotid Intima-Media Thickness Measurements in Cardiovascular Risk Prediction: A Meta-analysis. JAMA. 2012;308(8):796–803. DOI: 10.1001/jama.2012.9630
16. Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. European Heart Journal. 2020;41(1):111–88. DOI: 10.1093/eurheartj/ehz455
17. Jellinger PS, Handelsman Y, Rosenblit PD, Bloomgarden ZT, Fonseca VA, Garber AJ et al. American association of clinical endocrinologists and american college of endocrinology guidelines for management of dyslipidemia and prevention of cardiovascular disease. Endocrine Practice. 2017;23(Supplement 2):1–87. DOI: 10.4158/EP171764.APPGL
18. van den Oord SCH, Sijbrands EJG, ten Kate GL, van Klaveren D, van Domburg RT, van der Steen AFW et al. Carotid intima-media thickness for cardiovascular risk assessment: Systematic review and meta-analysis. Atherosclerosis. 2013;228(1):1–11. DOI: 10.1016/j.atherosclerosis.2013.01.025